Monuvir 200Mg - Anti-COVID Generic Drug Molnupiravir

Monuvir 200Mg - Anti-COVID Generic Drug Molnupiravir

Enquiry Now


Description

Monuvir 200Mg - Anti-COVID Generic Drug Molnupiravi

Additional Information

Molnupiravir is the world’s first oral pill to treat symptomatic COVID-19 which was approved by the UK’s Medicines and Healthcare products Regulatory Agency on 4 November 2021. Molnupiravir is originally developed by the US based pharma major Merck, Sharp & Dohme (MSD) and Ridgeback Biotherapeutics.


You May Also Like...

TESTIMONIALS